D’Arcy v. Myriad Genetics: A Demand for the “Made” or “Non-Information” and Clear Subject Matter?

In October 2015, the High Court of Australia (HCA) handed down D’Arcy v. Myriad Genetics and overturned the Full Court of the Federal Court of Australia by holding that key product claims from Myriad Genetics’ BRCA1 gene patent did not constitute manners of manufacture. Two years earlier, the Suprem...

Full description

Saved in:
Bibliographic Details
Published inIIC - International Review of Intellectual Property and Competition Law Vol. 47; no. 5; pp. 537 - 568
Main Author Lai, Jessica C.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2016
Subjects
Online AccessGet full text

Cover

Loading…